Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.35 (
matrix metalloproteinase 9
)
2,207
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutrophil granules contain secretory molecules that contribute to the implementation of all neutrophil functions. The molecular components that regulate the exocytosis of neutrophil granules have not been characterized. In this study, using small interfering RNA gene-targeting approaches and granulocytes from genetically modified mice, we characterized the Rab27a effectors JFC1/Slp1 and
Munc13-4
as components of the exocytic machinery of granulocytes. Using total internal reflection fluorescence microscopy analysis, we show that Rab27a and JFC1 colocalize in predocked and docked vesicles in granulocytes. Next, we demonstrate that JFC1-downregulated granulocytes have impaired myeloperoxidase secretion. Using immunological interference, we confirm that JFC1 plays an important role in azurophilic granule exocytosis in human neutrophils. Interference with Rab27a but not with JFC1 impaired
gelatinase B
secretion in neutrophils, suggesting that a different Rab27a effector modulates this process. In similar studies, we confirmed that
Munc13-4
regulates gelatinase secretion. Immunofluorescence analysis indicates that
Munc13-4
localizes at secretory organelles in neutrophils. Using neutrophils from a
Munc13-4
-deficient mouse model (Jinx), we demonstrate that
Munc13-4
plays a central role in the regulation of exocytosis of various sets of secretory organelles. However, mobilization of CD11b was not affected in
Munc13-4
-deficient neutrophils, indicating that secretory defects in these cells are limited to a selective group of exocytosable organelles.
...
PMID:The Rab27a effectors JFC1/Slp1 and Munc13-4 regulate exocytosis of neutrophil granules. 1893 52